Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhibo Zhao
Observed name:
Zhao, Zhibo
Institution:
Second Affiliated Hospital of Chongqing Medical University
Observed institutions:
Second Affiliated Hospital of Chongqing Medical University,
First Affiliated Hospital of University of South China,
Chongqing Medical University,
University of South China
ORCID:
0009-0000-4784-3134
Observed ORCID:
0009-0000-4784-3134
OpenAlex ID:
A5101437904
Targeting FDFT1 Reduces Cholesterol and Bile Acid Production and Delays Hepatocellular Carcinoma Progression Through the HNF4A/ALDOB/AKT1 Axis
2025
·
Dong Cai
, Guo‐Chao Zhong
, et al.
·
Advanced Science
·
36
PDF
Magic and mystery of microRNA‐32
2021
·
ZL Zeng
, Qingyun Zhu
, et al.
·
Journal of Cellular and Molecular Medicine
·
27
PDF
Inhibiting cholesterol de novo synthesis promotes hepatocellular carcinoma progression by upregulating prostaglandin E synthase 2‐mediated arachidonic acid metabolism under high fatty acid conditions
2023
·
Zhibo Zhao
, Xinyi Liu
, et al.
·
Cancer Science
·
18
N -glycosylation of SCAP exacerbates hepatocellular inflammation and lipid accumulation via ACSS2-mediated histone H3K27 acetylation
2024
·
Xuemei Li
, Xiaoqin Tang
, et al.
·
American Journal of Physiology-Gastrointestinal and Liver Physiology
·
14
L-lactate-driven PSMD14 lactylation and stabilization promote lactate production and ferroptosis resistance via ENO1 in intrahepatic cholangiocarcinoma
2026
·
Dong Cai
, Guo-Chao Zhong
, et al.
·
Cancer Letters
·
7
Integrating bioinformatics and experimental validation to reveal a novel VRK score as a prognostic and therapeutic biomarker in hepatocellular carcinoma
2025
·
Zhihao Fu
, Dufei Liu
, et al.
·
Frontiers in Immunology
·
1
City-level ETI scores.xlsx
2023
·
Shen, Yifan
, Shi, Xunpeng
, et al.
·
Figshare
Show more works
View as search
Works count:
8
Citation count:
103
H-index:
5
I10-index:
4
Year
Topic
Type